Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 570, pseudogene (RNU6-570P) is a processed pseudogene of the U6 small nuclear RNA gene family. U6 snRNA is an essential component of the spliceosome responsible for pre-mRNA splicing, but RNU6-570P itself is a non-functional, non-coding pseudogene with no established protein product, enzymatic activity, or direct role in disease or therapy. Pseudogenes of U6 snRNA are common in vertebrates and generally lack biological function; however, some pseudogenes in other gene families may have regulatory roles, but there is currently no evidence that RNU6-570P is a therapeutic target or implicated in disease mechanisms[2][3]. Justification: - This gene is a pseudogene, specifically a non-coding and likely non-functional copy of the highly conserved U6 small nuclear RNA gene, and not a receptor, enzyme, transporter, or known therapeutic target[3]. - No drug interactions, biomarker status, or disease associations have been reported in the literature for RNU6-570P. - There is nothing to suggest RNU6-570P itself has a role in cell signaling, transcription, or as a direct disease biomarker. - The entry is not misspelled but is not a therapeutic target in the standard sense; this would make `is_incorrect` true if you are seeking receptor/target-type genes. If you need information on the functional U6 snRNA, see "U6 spliceosomal RNA" which is involved in the spliceosome and essential RNA splicing in the nucleus[3]. RNU6-570P is one of many processed pseudogenes derived from this family.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 570, pseudogene (RNU6-570P).